Results

Total Results: 1,795 records

Showing results for "cost".

  1. effectivehealthcare.ahrq.gov/products/long-term-care-adults/research-protocol
    December 20, 2011 - Assessing the Cost of Care Assessing costs in the context of LTC requires attention to expenses associated … Meaningful cost comparisons between HCBS and institutional care must determine and specify the exact … Meanwhile, some cost analyses of HCBS include all public subsidies received by HCBS clients (e.g., rent … We will consider costs separately from the question of effectiveness; this review will not look at cost-effectiveness … Costs may include direct costs of care as well as costs such as resource utilization and family burden
  2. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-the-disabled-and-elderly-with-multiple-comorbidities-what-is-the-comparative-effectiveness-of-physician-housecalls-on-outcomes-and-total-cost
    November 21, 2012 - comorbidities, what is the comparative effectiveness of physician housecalls on outcomes and total cost … There is little known about comparative mortality rates in this high-cost, complex, multi-morbid patients … The Independence at Home demonstration now underway will most likely confirm dramatic cost savings with … Newer studies confirm major cost savings, but my concern is that this might be related to the strong … Very little is known about housecalls beyond the cost savings.
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/long-term-care-adults_research-protocol.pdf
    December 20, 2011 - Assessing the Cost of Care Assessing costs in the context of LTC requires attention to expenses associated … Meaningful cost comparisons between HCBS and institutional care must determine and specify the exact … Meanwhile, some cost analyses of HCBS include all public subsidies received by HCBS clients (e.g., … cost-effectiveness. … Costs may include direct costs of care as well as costs such as resource utilization and family burden
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/mgmt-hnhc-patients-protocol.pdf
    November 07, 2019 - success in these models depends, in large part, on their effectiveness in addressing the care and costs … One direct approach is to identify the patients with the highest costs during a historical time period … care use/costs No increased risk for high health care use/costs Population: Identification of HNHC … patients (KQ 1 a-e) HNHC patients: High use/costs are preventable or modifiable High use/costs … ACOs at a crossroads: costs, risk and MACRA. A NAACOS policy white paper.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-presentation-format_research.pdf
    January 01, 2019 - parameterize models (nonsystematic review, systematic review, primary data, not stated); whether costs … proceed to calculate EVSI, the expected value of information from a sample n (and compare it to the costs … effectiveness plane scatter plot is a bivariate scatter plot of costs (measured in dollars in this … The interviewer proposed that operational definitions of feasibility and future research costs could … effectiveness analysis 2006 BMJ 18793033 Costs and effects of secondary prevention with perindopril
  6. effectivehealthcare.ahrq.gov/products/health-data-mapping/protocol
    December 03, 2019 - Partial economic evaluations and other cost analyses or descriptions are out of scope as costs are unable … We will note whether cost analyses were reported. … analysis that did not relate cost to effectiveness. 3/17/20 Table 1, Outcomes INCLUDE … Partial economic evaluations and other cost analyses or descriptions are out of scope as costs are unable … The sentence on partial economic evaluations and other cost analyses was deleted based on the earlier
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
    March 17, 2020 - Partial economic evaluations and other cost analyses or descriptions are out of scope as costs are … We will note whether cost analyses were reported. … analysis that did not relate cost to effectiveness. 3/17/20 Table 1, Outcomes INCLUDE: Process … Partial economic evaluations and other cost analyses or descriptions are out of scope as costs … The sentence on partial economic evaluations and other cost analyses was deleted based on the earlier
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/economic-evaluation-tools_research.pdf
    October 01, 2012 - " TX "cost analysis" TX "economic analysis" TX "Decision making" TX "health policy" TX reimbursement … Opportunity costs b. Charges c. Deflated charges (using cost-to-charge ratios) d. … Type and adequacy of comparisons* Costs 11. Cost perspective 12. Cost coverage 13. … Resources should be relevant to the perspective and described in natural units before a cost analysiscosts and effectiveness, and incremental cost effectiveness ratios 25.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/long-term-care-adults-future_research.pdf
    July 01, 2013 - Evidence was also insufficient for cost comparisons. … Evidence was also insufficient for cost comparisons. … Need to make cost comparisons that account for LTC costs and all other relevant costs, including the … cost of room and board, costs of public subsidies (rent, transportation, and food stamps), cost of … and unobserved variables that may create a risk of bias Interest among researchers Duration Cost
  10. effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - The $294,000 annual cost of ivacaftor therapy was identified as a potentially controversial issue. … was set at about $294,000. 11 The manufacturer has implemented stratified pricing terms based on … patient insurance status and income. 12 While ivacaftor’s annual price is high, pricing was purported … The $294,000 annual cost of ivacaftor therapy was identified as a potentially controversial issue. … representing a health systems perspective estimated that treating all eligible patients with ivacaftor would cost
  11. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - In October 2013, JAMA published an editorial (by O’Sullivan and colleagues) on orphan-drug pricing, … indicating that pricing models are unsustainable and using Kalydeco as an example. … for a monthly supply.11 The manufacturer has implemented 3 stratified pricing that is based … Although the cost of azithromycin therapy would be added to current treatment costs, its low cost and … Pricing for orphan drugs: will the market bear what society cannot?
  12. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - pharmacies.10 The manufacturer has implemented stratified pricing that is based on patient insurance … Although the cost of azithromycin therapy would be additive to current treatment costs, its low cost … perhaps even cost-saving impact. 8 References 1. … Kalydeco pricing. [internet]. Santa Monica (CA): GoodRx, Inc. [accessed 2013 Jun 12]. [5 p]. … Azithromycin pricing. [internet]. Santa Monica (CA): GoodRx, Inc. [accessed 2013 Jun 12]. [6 p].
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_disposition-comments.pdf
    December 01, 2011 - On a Medicare allowable cost comparison basis, a full course of CyberKnife SBRT costs considerably … Two additional cost analyses to consider are: Corcoran AT, Peele PB, Benoit RM. … Cost comparison between watchful waiting with active surveillance and active treatment of clinically … analysis of prostate cancer treatments, and the misconceptions regarding the costs of proton therapy … Any cost comparisons and economic evaluations should either (i) not be included in the Final Report
  14. effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
    January 01, 2012 - Ivacaftor costs about $294,000 per year, and some financial analysts expect that third-party payers … Additionally, the manufacturer is expected to implement stratified pricing terms based on patient insurance … patients aged 6 years and older who have a G551D mutation in the CFTR gene. 8 Ivacaftor’s annual pricing … was set at about $294,000. 9 The manufacturer has implemented stratified pricing terms based on patient … insurance status and income. 10 While ivacaftor’s annual price is high, pricing was purported to
  15. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
    July 01, 2013 - The cost of liraglutide at the dosage used to treat obesity is expected to be greater than the cost … drug pricing resource GoodRX lists pricing for 30-day supplies ranging from $149.99 to $159.99 at various … As of June 2013, the online U.S. drug pricing resource GoodRX listed pricing for 30-day supplies ranging … can afford the cost. … Qsymia pricing. [internet]. Santa Monica (CA): GoodRx, Inc.; 2012 Nov [accessed 2012 Nov 6].
  16. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/cost-effective-long-term-care-of-the-frail-elderly
    February 18, 2011 - Cost effective long term care of the frail elderly Does your question include a comparison of different
  17. effectivehealthcare.ahrq.gov/products/diabetes-foot-ulcer-amputation-economics/research
    March 08, 2011 - The cost of care for these beneficiaries is substantial, at about $33,000 for total reimbursement of … The actual national cost burden of diabetes is thought to exceed $174 billion, including the social cost … of intangibles such as pain and suffering, care provided by nonpaid caregivers, medical costs associated … with undiagnosed diabetes, and diabetes-attributed costs. … With this background in mind, the goal of this Data Points brief is to evaluate the utilization and costs
  18. effectivehealthcare.ahrq.gov/sites/default/files/cer-216-telehealth-disposition-comments.pdf
    April 24, 2019 - Profound changes in the healthcare system overall are also rapidly impacting the costs and delivery … Regarding the cost model, w e acknow ledge that this is not a typical approach. … How ever, the simplicity of a cost-minimization analysis did not w arrant a probabilistic sensitivity … We now have an opportunity to begin to measure outcomes and costs in a consistent w ay. … analyses and additional models.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-216-telehealth-disposition-comments.pdf
    April 24, 2019 - Profound changes in the healthcare system overall are also rapidly impacting the costs and delivery … Regarding the cost model, w e acknow ledge that this is not a typical approach. … How ever, the simplicity of a cost-minimization analysis did not w arrant a probabilistic sensitivity … We now have an opportunity to begin to measure outcomes and costs in a consistent w ay. … analyses and additional models.
  20. effectivehealthcare.ahrq.gov/products/high-utilizers-health-care
    December 04, 2019 - Management of High-Need, High-Cost Patients: A Realist and Systematic Review Timeline … December 04, 2019 Research Protocol Management of High-Need, High-Cost

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: